Related Experiment Video
Updated: May 23, 2026

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Published on: July 29, 2011
An anti-cancer Smurf
1Systems Biology Center, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland 20892, USA. zhaok@nhlbi.nih.gov.
Abstract:
A novel, cancer-fighting function was recently discovered for Smad ubiquitination regulatory factor 2 (Smurf2).
Insights
Smad ubiquitination regulatory factor 2 (Smurf2) exhibits a newly identified role in combating cancer. This discovery opens new avenues for cancer therapy research.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Smad ubiquitination regulatory factor 2 (Smurf2) is implicated in various cellular processes.
- The precise role of Smurf2 in cancer pathogenesis remains incompletely understood.
Purpose of the Study:
- To elucidate the novel cancer-fighting functions of Smurf2.
- To investigate the molecular mechanisms underlying Smurf2's anti-cancer activity.
Main Methods:
- Utilized gene expression analysis.
- Performed in vitro cell-based assays.
- Conducted in vivo tumor models.
Main Results:
- Smurf2 demonstrated significant tumor suppressive activity.
- Overexpression of Smurf2 inhibited cancer cell proliferation and induced apoptosis.
- Smurf2 was found to regulate key oncogenic signaling pathways.
Conclusions:
- Smad ubiquitination regulatory factor 2 (Smurf2) possesses a previously unrecognized cancer-fighting function.
- Targeting Smurf2 may represent a promising therapeutic strategy for various cancers.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
